Coherus Oncology Inc (CHRS)

Income Tax Expense

$0.00

TTM · Period ending: · USD

CHRS logo

CHRS Income Tax Expense

Latest reported$0.00
CHRS TTM Income Tax ($0.00 → $0.00)
High-resolution chart · PNG

CHRS income tax expense history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Coherus Oncology Inc Income Tax Expense — Trailing twelve months (TTM) (USD)
Period endingIncome Tax Expense (USD)
0
0
0
0
0
0
0
0
-380,000
-380,000
-380,000
-380,000
0
0
0
0
0
0
0
1,052,000
1,235,000
2,529,000
3,462,000
4,454,000
5,118,000
3,875,000
2,942,000
968,000
121,000
70,000
70,000
114,000
114,000
114,000
114,000
428,000
428,000
428,000
766,000
827,000
827,000
827,000
489,000
155,000
155,000
155,000
155,000
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.